| Lightcalls.com |
|
|
![]() |
CONGRATULATIONS The Queen Alexandra...CONGRATULATIONS The Queen Alexandra Foundation for Children has named tap [i]or[/i] pat Chandler, FCA, as a recent member of its board. The Foundation raises, invests, and stewards supplys to support the physical, mental, and social well-being of more than 20000 Vancouver Island children, youth, and families each year. Daniel Gumprich, CA-CBV, has joined Sterling Shoe Income store as chief financial officer. Sterling Shoe is a leading, Vancouver-based, independent footwear retailer operating in five Canadian provinces below four separate retail banners: Sterling, Joneve Shoe Warehouse, and Freedman's. Bill Payne, CA, is the strange chair of the 2005/2006 Douglas guild Foundation board. The Burnaby resident has a drawn out history of community involvement-primarily in fresh Westminster-including the Rotary Club, the Westminster Foundation, and the modern Westminster Hyack Festival. Varshney Capital Corp.'s 9th annual charity golf tournament, organized by means of Anuja S. Varshney, CA, raised $60000 for St Paul's Hospital Foundation and the BC Children's Hospital Foundation. Since its inception, the golf tournament has raised $466000 for local children's charities. (Varshney Capital Corp. is speed by Hari B. Varshney, FCA, and Praveen K Varshney, CA.) NOTICES TO THE EDITOR Send your notices to mcrae@ica.bc.ca MISSING MEMBERS We're trying to locate the following members. If you know of their whereabouts, please contact Reba Pat in member records at pat@ica.bc.ca. Mr James C Barclay, CA Mr Keppel C Boulton, CA Mr Ian J Brown CA Mr Denis V Burnett CA Mr John R Ducharme, CA Mr William R Fairgrieve, CA Mr Alan M Jone CA Mr Kwet L Kong CA Mr Alan R Laing, CA M Tsui-Ming Lam, CA Mr C Kenneth Macdonald, CA Mr Harold E McFarlane, CA Mr John M Reid, CA Mr Gilbert F Shaw, CA Mr John s Shaw, CA Mr. Robert Smith, CA Mr Robert J Sundberg, CA NOTES in succession LICENSING Approved at the September 16 2005 Practice Review & Licensing Committee Meeting: Practice Licence Applications Approved At its meeting of September 16 2005 the following applications for practice licences were approved according to the Practice Review & Licensing Committee, in accordance with Bylaws 61 Ii & ii: Cancelled Licences and Mergers At its meeting of September 16 2005 the Practice Review & Licensing Committee received the following listing of firms no longer in public practice in a less degree than these names: Copyright Institute of Chartered Accountants of British Columbia Oct 2005 |
![]() |
Other Articles
-Morphotek will collaborat...-Eksigent Technologies nam... -The benefits of outsourci... -Sartorius Corporation ... -In our previous column, w... -Efoora appointed Michael ... -Affymax appointed Anne-Ma... -Traditionally, continuous... -New Brunswick Scientific ... -The German-American firm ... -Don G. Burstyn, formerly ... -American patients are mor... -Summary Prior to va... -BioPharm Editorial Adviso... -Australia agreed to spend... -The Biotechnology Industr... -Ambion, The RNA Company i... -Therapies based on living... -A recent survey found tha... -ViroLogic will acquire Ac... -Cardinal Health named Joh... -One of the greatest chall... -As the president of a sma... -Sweden-based Biovitrum wi... -Nanogen appointed David L... -The Experion Process Know... -Although biomedical resea... -The Supreme Court of Cana... -Netherlands-based DSM Bio... -David A. Smoller joined S... -A few months ago, I wrote... -Panacos Pharmaceuticals w... -Karen K. Vaccaro will res... -Acceleron Pharma appointe... -Two quarterly meetings of... -Illinois-based Abbot Labo... -FKI Logistics announced t... -The following corrections... -It its widest definition,... -UK-based Xcellsyz will li... -Andrew P. Aromando joined... -Invitrogen's comprehensiv... -Last month, we described ... -The Swiss life sciences c... -Protein Design Labs (PDL)... -Model It HNMR, the newest... -Tech transfer, like chang... -QLT and Atrix Laboratorie... -Dendreon announced Christ... -Baxter Pharmaceutical Sol... -The biopharmaceutical ind... -GlaxoSmithKline announced... -Montreal-based Caprion Ph... -Xenova Group recently ann... -Cole-Parmer's new 192-pag... -Over the last decade ther... -Benchmark your facility p... -As biotechnology organiza... -Frederick D. Sancillo, fo... -Insmed acquired a recombi... -Baxter Pharmaceutical Sol... -Model It HNMR, the newest... -DA's regulation 21 CFR Pa... -Robert P. Ryan joined Ath... -A new report from Busines... -Biotest offers a complete... -Swagelok offers a brochur... -Partnering is a global ph... -Human Genome Sciences CEO... -Shorten the process devel... -The licensure of biotechn... -Rodger Currie joined Amge... -The GEA Filtration Model ... -A multi-channel chemistry... -From June 6-9, San Franci... -Skanska USA Building Inc.... -New Brunswick Scientific'... -AVI BioPharma appointed P... -Ambion, The RNA Company, ... -"If you want to be a... -Xcellerex appointed Susan... -Researchers identified th... -Cool Spring Business Park... -In October 2003, Shenzhen... -Laureate Pharma appointed... -After a 6-5 vote by Calif... -QSourcing, a service of Q... -The recent discovery of &... -Affymax added Douglas L. ... -USDA recently approved tw... -BioPharm International is... -Serologicals has released... -This document by Shenzhen... -Robert Bronstein joined A... -Gloucester Gains Fujisawa... -With more than 30 years o... -Pall's SUPRAdisc II depth... -In today's competitive ma... -Protein Design Labs repor... -Charles A. Rice will repl... -AstraZeneca's Faslodex (f... |
| . |